1,604
Participants
Start Date
January 31, 2017
Primary Completion Date
December 1, 2021
Study Completion Date
November 1, 2022
Cryoprecipitate
Cryoprecipitate is a blood product high in fibrinogen. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).
Red Blood Cells
RBCs are utilized as part of the Massive Transfusion protocol for hemorrhage control.
Plasma
Plasma is utilized as part of the Massive Transfusion protocol for hemorrhage control.
Platelets
Platelets are utilized as part of the Massive Transfusion protocol for hemorrhage control.
Whole Blood
Whole Blood is utilized as part of the Massive Transfusion protocol for hemorrhage control.
The University of Texas Health Science Center at Houston, Houston
Queen Elizabeth Hospital, Birmingham
Royal Sussex County Hospital, Brighton
Southmead Hospital, Bristol
Addenbrooke's Hospital, Cambridge
University Hospital of Wales, Cardiff
University Hospital of Coventry and Warwickshire, Coventry
Hull Royal Infirmary, Hull
Leeds General Infirmary, Leeds
University Hospital Aintree, Liverpool
Royal London Hospital, London
King's College Hospital, London
St. George's Hospital, London
St. Mary's Hospital, London
Manchester Royal Infirmary, Manchester
Salford Royal Hospital, Manchester
James Cook University Hospital, Middlesbrough
Royal Victoria Infirmary, Newcastle upon Tyne
Queens Medical Centre, Nottingham
John Radcliffe Hospital, Oxford
Derriford Hospital, Plymouth
Royal Preston Hospital, Preston
Northern General Hospital, Sheffield
University Hospital Southampton, Southampton
University Hospital of North Staffordshire, Stoke-on-Trent
Lead Sponsor
Queen Mary University of London
OTHER
NHS Blood and Transplant
OTHER_GOV
Bryan Cotton
OTHER